Related Experiment Videos
Prostaglandins and primary dysmenorrhoea
Acta Biologica Et Medica Germanica
|January 1, 1978
Summary
Prostaglandin F2alpha (PGF2alpha) levels are significantly higher in women with dysmenorrhea (painful periods). Treatment with Indomethacin reduced PGF2alpha and improved symptoms, indicating PGF2alpha
Area of Science:
- Reproductive Endocrinology
- Biochemistry
Background:
- Dysmenorrhea, or painful menstruation, is a common gynecological condition.
- Prostaglandins (PGs) are implicated in the pathophysiology of dysmenorrhea.
Purpose of the Study:
- To investigate prostaglandin levels in menstrual blood of women with and without dysmenorrhea.
- To evaluate the effect of Indomethacin on prostaglandin levels and dysmenorrhea symptoms.
Main Methods:
- Radioimmunoassay (RIA) was used to determine prostaglandin E1 (PGE1) and F2alpha (PGF2alpha) levels in menstrual blood from 100 patients.
- Patients were categorized into groups based on menstrual cycle patterns and presence of dysmenorrhea.
Main Results:
- Significantly higher PGF2alpha concentrations were found in menstrual blood of women with dysmenorrhea compared to healthy controls (p < 0.01).
- The ratio of investigated PGs was shifted towards PGF2alpha in dysmenorrhea.
- Indomethacin treatment reduced PGF2alpha levels by up to 15% (p < 0.01) and led to significant symptom improvement in treated patients.
Conclusions:
- Elevated PGF2alpha in menstrual blood is strongly associated with dysmenorrhea.
- Pharmacological reduction of PGF2alpha with Indomethacin effectively alleviates dysmenorrhea symptoms.